United Therapeutics Corporation
Martine A Rothblatt (Chairperson & CEO) sells UTHR shares
AI-generated summary
Chairperson & CEO, Director Martine A Rothblatt exercised 9,500 stock options at an average price of $117.76, valued at $1,118,720, and sold 9,500 shares of common stock at an average price of $593.99, valued at $5,642,869.59. The transactions were made indirectly by Trust under a Rule 10b5-1 trading plan adopted on November 7, 2025. Following these transactions, the insider indirectly holds 324,443 shares of common stock.
Key facts
- Insider
- Martine A Rothblatt · Chairperson & CEO, Director
Rule 10b5-1 plan · adopted Nov 7, 2025
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +9,500 | $117.76 | $1,118,720.00 | 333,943 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F3, F2 | −25 | $584.20 | $14,605.02 | 333,918 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F4, F2 | −215 | $585.93 | $125,976.00 | 333,703 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F5, F2 | −320 | $586.59 | $187,709.28 | 333,383 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F6, F2 | −271 | $588.16 | $159,390.60 | 333,112 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F7, F2 | −292 | $589.18 | $172,039.80 | 332,820 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F8, F2 | −301 | $590.31 | $177,684.12 | 332,519 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F9, F2 | −736 | $591.56 | $435,388.68 | 331,783 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F10, F2 | −1,172 | $592.68 | $694,625.06 | 330,611 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F11, F2 | −961 | $593.57 | $570,424.04 | 329,650 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F12, F2 | −991 | $594.66 | $589,305.48 | 328,659 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F13, F2 | −1,346 | $595.46 | $801,483.91 | 327,313 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F14, F2 | −1,324 | $596.74 | $790,078.46 | 325,989 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F15, F2 | −1,299 | $597.61 | $776,297.99 | 324,690 | Indirect (by Trust) |
| Nov 11, 2026 | S · open-market saleFootnotes F1, F16, F2 | −247 | $598.63 | $147,861.14 | 324,443 | Indirect (by Trust) |
| Nov 11, 2026 | M · exercise or conversion of a derivativeStock OptionFootnotes F1, F20, F21 | −9,500 | $0.00 | $0.00 | 43,410 | Indirect (by Trust) |
Footnotes
- F1 This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10 This transaction was executed in multiple trades at prices ranging from $592.14 to $593.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11 This transaction was executed in multiple trades at prices ranging from $593.15 to $594.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12 This transaction was executed in multiple trades at prices ranging from $594.16 to $595.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13 This transaction was executed in multiple trades at prices ranging from $595.16 to $596.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14 This transaction was executed in multiple trades at prices ranging from $596.17 to $597.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15 This transaction was executed in multiple trades at prices ranging from $597.17 to $598.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16 This transaction was executed in multiple trades at prices ranging from $598.50 to $598.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F17 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F18 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F19 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F2 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F20 These stock options vested in equal one-third installments on March 15, 2021, 2022 and 2023.
- F21 Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F3 This transaction was executed in multiple trades at prices ranging from $584.00 to $584.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4 This transaction was executed in multiple trades at prices ranging from $585.12 to $586.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5 This transaction was executed in multiple trades at prices ranging from $586.33 to $587.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6 This transaction was executed in multiple trades at prices ranging from $587.75 to $588.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7 This transaction was executed in multiple trades at prices ranging from $588.87 to $589.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8 This transaction was executed in multiple trades at prices ranging from $589.88 to $590.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9 This transaction was executed in multiple trades at prices ranging from $591.06 to $592.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More UTHR filings
- 4
Filed Nov 12, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 10, 2026
- 4
Filed Nov 9, 2026
- 144
Filed Nov 9, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.